ARTICLE | Company News
Bostwick, Metabolon sales and marketing update
November 11, 2013 8:00 AM UTC
Bostwick will exclusively market Metabolon's Prostarix prostate cancer diagnostic in the U.S. The test is a non-invasive test that quantifies sarcosine and other biomarkers excreted into urine to stra...